EDGAR Filing Documents for 0001564590-21-015137

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001564590-21-015137

Filing Date

2021-03-24

Accepted

2021-03-24 17:02:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	ktra-s3.htm	S-3	565971
2	EX-4.22	ktra-ex422_6.htm	EX-4.22	658280
3	EX-4.23	ktra-ex423_7.htm	EX-4.23	552122
4	EX-5.1	ktra-ex51_8.htm	EX-5.1	31412
5	EX-5.2	ktra-ex52_9.htm	EX-5.2	31794
6	EX-23.1	ktra-ex231_55.htm	EX-23.1	3203
7	EX-23.2	ktra-ex232_56.htm	EX-23.2	3123
8	GRAPHIC	gc0bo2pefdks000001.jpg	GRAPHIC	6200
9	GRAPHIC	gsnwmfxf1sd0000001.jpg	GRAPHIC	7871
10	GRAPHIC	geqjbfr2ghmd000001.jpg	GRAPHIC	5485
11	GRAPHIC	gsnwmfxf1sd0000002.jpg	GRAPHIC	7871
	Complete submission text file	0001564590-21-015137.txt		1885474

Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130

Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364

Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)